Question: Is there a clear advantage in survival with the use of Polichemotherapy rather than Monochemotherapy as first line treatment?

David Wilson answered on 4 Jun 2019:

We’re moving into an age of Personalised Medicine. We are all unique. Our health is determined by our inherent differences combined with our lifestyles and environment. By combining and analysing information about our genome, with other clinical and diagnostic information, patterns can be identified that can help to determine our individual risk of developing disease; detect illness earlier; and, determine the most effective interventions to help improve our health, be they medicines, lifestyle choices, or even simple changes in diet.

We are also constantly discovering new drugs and new ways of treating disease. Trying to work out the best way to use drugs to treat patients require clinical trials which can seem very complicated but they are really just designed to answer your question. The tricky thing is we’re not all the same and neither are the diseases we get and so what works well in one person might not have the same effect in another person or different disease.

Personalised medicine will help get the right treatment to the right person.